SEP 15, 2020 7:00 AM PDT

Common Spice Relieves Eye Inflammation in Dogs, Human Studies to Follow

WRITTEN BY: Tara Fernandez

A therapeutic made from turmeric has been shown to help reduce the effects of a painful inflammatory eye condition in dogs, known as uveitis. Erin Scott, an assistant professor at the College of Veterinary Medicine & Biomedical Sciences at Texas A&M University, led the study which was published recently in Science Advances.

Following cataract surgery, dogs typically suffer from uveitis, when postoperative inflammation leads to pain and vision impairment. A similar condition also occurs in humans undergoing eye surgeries. The researchers looked to curcumin, the active anti-inflammatory in turmeric, as a possible antidote. This molecule has been the subject of interest from both scientists and health enthusiasts for its purported antioxidant and pain-relieving properties.

One of the major barriers to using curcumin therapeutically is its low bioavailability — it’s difficult for the body to absorb it and for it to reach high enough concentrations at the anatomical site where it’s needed. To overcome this, the researchers developed a new curcumin formulation using nanotechnology to pull the active ingredient into cells, thus boosting its potency and efficacy.

A big plus for curcumin is that there are very few, if any, adverse side effects to taking it therapeutically. “Current treatments include a combination of systemic and topical anti-inflammatory medications, either in the form of steroids or non-steroidal anti-inflammatory drugs (NSAYSs),” said Scott.

“While both these medications are effective in the treatment of uveitis, they can cause unwanted side effects, such as vomiting, diarrhea, stomach ulcers, negatively impact kidney and liver function, and increase glucose levels in diabetic patients.”

Next steps? Testing their curcumin formulation in human disease models. “This medication may translate to the treatment of cataracts and uveitis in humans,” said Scott. 

“By studying animal patients with naturally occurring eye diseases, our findings may accelerate the development of medications to benefit both animals and humans.”

 

 

Sources: Texas A&M, Science Advances.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
DEC 03, 2020
Immunology
Cytokine Storms Aren't to Blame for COVID Respiratory Failures
DEC 03, 2020
Cytokine Storms Aren't to Blame for COVID Respiratory Failures
Many of the life-threatening symptoms of COVID-19 have been pinned on “cytokine storms” — immune syste ...
DEC 28, 2020
Genetics & Genomics
Mapping Networks of Gene Expression in Cells
DEC 28, 2020
Mapping Networks of Gene Expression in Cells
Every cell contains our whole genome, but not all genes are turned on all the time; gene expression has to be very caref ...
JAN 18, 2021
Immunology
Arthritis Drug Approved for Critically Ill COVID Patients
JAN 18, 2021
Arthritis Drug Approved for Critically Ill COVID Patients
Critically ill COVID patients in the U.K. may receive an arthritis drug after a study showed that treatment lowered mort ...
FEB 02, 2021
Immunology
Tumors Under Seige by Cancer-Killing Salmonella
FEB 02, 2021
Tumors Under Seige by Cancer-Killing Salmonella
Salmonella is a genus of rod-shaped bacteria, often given a bad rap thanks to its association with food poisoning. But c ...
FEB 07, 2021
Microbiology
Positive Results From A Clinical Trial of an HIV Vaccine
FEB 07, 2021
Positive Results From A Clinical Trial of an HIV Vaccine
After years of effort, researchers are reporting that there were encouraging results from a phase 1 clinical trial which ...
Loading Comments...